Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
J Virol. 2014 May;88(10):5543-58. doi: 10.1128/JVI.00041-14. Epub 2014 Mar 5.
Although significant clinical efficacy and safety of rotavirus vaccines were recently revealed in many countries, the mechanism of their attenuation is not well understood. We passaged serially a cell culture-adapted murine rotavirus EB strain in mouse pups or in cell cultures alternately and repeatedly and fully sequenced all 11 genes of 21 virus samples passaged in mice or in cell cultures. Sequence analysis revealed that mouse-passaged viruses that regained virulence almost consistently acquired four kinds of amino acid (aa) substitutions in VP4 and substitution in aa 37 (Val to Ala) in NSP4. In addition, they gained and invariably conserved the 3' consensus sequence in NSP1. The molecular changes occurred along with the acquisition of virulence during passages in mice and then disappeared following passages in cell cultures. Intraperitoneal injection of recombinant NSP4 proteins confirmed the aa 37 site as important for its diarrheagenic activity in mice. These genome changes are likely to be correlated with rotavirus virulence.
Serial passage of a virulent wild-type virus in vitro often results in loss of virulence of the virus in an original animal host, while serial passage of a cell culture-adapted avirulent virus in vivo often gains virulence in an animal host. Actually, live attenuated virus vaccines were originally produced by serial passage in cell cultures. Although clinical efficacy and safety of rotavirus vaccines were recently revealed, the mechanism of their attenuation is not well understood. We passaged serially a murine rotavirus by alternating switch of host (mice or cell cultures) repeatedly and sequenced the eleven genes of the passaged viruses to identify mutations associated with the emergence or disappearance of virulence. Sequence analysis revealed that changes in three genes (VP4, NSP1, and NSP4) were associated with virulence in mice. Intraperitoneal injection of recombinant NSP4 proteins confirmed its diarrheagenic activity in mice. These genome changes are likely to be correlated with rotavirus virulence.
虽然轮状病毒疫苗在最近的许多国家中显示出显著的临床疗效和安全性,但它们的减毒机制尚未得到很好的理解。我们通过在小鼠或细胞培养物中交替反复传代,对一种细胞适应性鼠轮状病毒 EB 株进行了连续传代,对在小鼠或细胞培养物中传代的 21 个病毒样本的所有 11 个基因进行了完全测序。序列分析显示,恢复毒力的小鼠传代病毒几乎一致地在 VP4 中获得了四种氨基酸(aa)替换,在 NSP4 中获得了 aa37(缬氨酸到丙氨酸)替换。此外,它们获得了并始终保守了 NSP1 中的 3' 保守序列。这些分子变化伴随着在小鼠中的传代过程中获得毒力而发生,然后在细胞培养物中的传代过程中消失。重组 NSP4 蛋白的腹腔注射证实 aa37 位点对其在小鼠中的致腹泻活性很重要。这些基因组变化可能与轮状病毒的毒力相关。
在体外对一种强毒野生型病毒进行连续传代,通常会导致该病毒在原始宿主动物中的毒力丧失,而对一种细胞适应性无毒性病毒在体内进行连续传代,通常会在动物宿主中获得毒力。实际上,活减毒疫苗最初是通过在细胞培养物中连续传代产生的。尽管最近发现了轮状病毒疫苗的临床疗效和安全性,但它们的减毒机制尚不清楚。我们通过在宿主(小鼠或细胞培养物)之间反复交替传代,对一种鼠轮状病毒进行了连续传代,并对传代病毒的 11 个基因进行了测序,以确定与毒力出现或消失相关的突变。序列分析显示,三个基因(VP4、NSP1 和 NSP4)的变化与小鼠中的毒力有关。重组 NSP4 蛋白的腹腔注射证实了其在小鼠中的致腹泻活性。这些基因组变化可能与轮状病毒的毒力有关。